NCT05722964View on ClinicalTrials.gov

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 29, 2023

Primary Completion Date

August 7, 2024

Study Completion Date

August 7, 2024

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

SHR-1906

Intravenous injection

DRUG

SHR-1906

Intravenous injection

DRUG

Placebo

Placebo，Intravenous injection

Trial Locations (1)

100029

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY